IDEXX LABORATORIES INC /DE Exchange Rate Effect on Cash
IDEXX LABORATORIES INC /DE (IDXX) reported Exchange Rate Effect on Cash of -$4.77 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents · last filed 2019-02-15
- IDEXX LABORATORIES INC /DE effect of exchange rate on cash and cash equivalents for the quarter ending 2018-03-31 was $1.33M, a 30.90% decline year-over-year.
- IDEXX LABORATORIES INC /DE effect of exchange rate on cash and cash equivalents for the quarter ending 2017-03-31 was $1.93M, a 41.98% decline year-over-year.
- IDEXX LABORATORIES INC /DE effect of exchange rate on cash and cash equivalents for the quarter ending 2016-03-31 was $3.33M.
- IDEXX LABORATORIES INC /DE effect of exchange rate on cash and cash equivalents for the quarter ending 2015-03-31 was -$1.91M, a 256.67% decline year-over-year.
- IDEXX LABORATORIES INC /DE effect of exchange rate on cash and cash equivalents for fiscal 2018 was -$4.77M, a 176.88% decline from fiscal 2017.
- IDEXX LABORATORIES INC /DE effect of exchange rate on cash and cash equivalents for fiscal 2017 was $6.20M.
- IDEXX LABORATORIES INC /DE effect of exchange rate on cash and cash equivalents for fiscal 2016 was -$54.00K.
- IDEXX LABORATORIES INC /DE effect of exchange rate on cash and cash equivalents for fiscal 2015 was -$5.95M.
| Period end | Effect of Exchange Rate on Cash and Cash Equivalents 3 month | Effect of Exchange Rate on Cash and Cash Equivalents 6 month | Effect of Exchange Rate on Cash and Cash Equivalents 9 month | Effect of Exchange Rate on Cash and Cash Equivalents 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$4.77M 10-K · filed 2019-02-15 | |||
| 2018-09-30 | -$3.69M 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | -$3.81M 10-Q · filed 2018-08-01 | |||
| 2018-03-31 | $1.33M 10-Q · filed 2018-05-04 | |||
| 2017-12-31 | $6.20M 10-K · filed 2019-02-15 | |||
| 2017-09-30 | $6.13M 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | $4.41M 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | $1.93M 10-Q · filed 2018-05-04 | |||
| 2016-12-31 | -$54.00K 10-K · filed 2019-02-15 | |||
| 2016-09-30 | $4.34M 10-Q · filed 2017-10-31 | |||
| 2016-06-30 | $3.53M 10-Q · filed 2017-08-01 | |||
| 2016-03-31 | $3.33M 10-Q · filed 2017-04-28 | |||
| 2015-12-31 | -$5.95M 10-K · filed 2018-02-16 | |||
| 2015-09-30 | -$5.07M 10-Q · filed 2016-11-01 | |||
| 2015-06-30 | -$588.00K 10-Q · filed 2016-08-02 | |||
| 2015-03-31 | -$1.91M 10-Q · filed 2016-04-29 | |||
| 2014-12-31 | -$8.52M 10-K · filed 2017-02-17 | |||
| 2014-09-30 | -$4.29M 10-Q · filed 2015-10-28 | |||
| 2014-06-30 | $1.56M 10-Q · filed 2015-07-30 | |||
| 2014-03-31 | $1.22M 10-Q · filed 2015-04-28 | |||
| 2013-12-31 | -$2.41M 10-K · filed 2016-02-17 | |||
| 2013-09-30 | -$1.28M 10-Q · filed 2014-10-24 | |||
| 2013-06-30 | -$3.05M 10-Q · filed 2014-07-25 | |||
| 2013-03-31 | -$1.64M 10-Q · filed 2014-04-25 | |||
| 2012-12-31 | $1.16M 10-K · filed 2015-02-17 | |||
| 2012-09-30 | $639.00K 10-Q · filed 2013-10-22 | |||
| 2012-06-30 | -$461.00K 10-Q · filed 2013-07-23 | |||
| 2012-03-31 | $320.00K 10-Q · filed 2013-04-23 | |||
| 2011-12-31 | $933.00K 10-K · filed 2014-02-18 | |||
| 2011-09-30 | $2.04M 10-Q · filed 2012-10-19 | |||
| 2011-06-30 | $2.27M 10-Q · filed 2012-07-20 | |||
| 2011-03-31 | $1.27M 10-Q · filed 2012-04-20 | |||
| 2010-12-31 | $1.31M 10-K · filed 2013-02-19 | |||
| 2010-09-30 | $884.00K 10-Q · filed 2011-10-21 | |||
| 2010-06-30 | -$3.11M 10-Q · filed 2011-07-22 | |||
| 2010-03-31 | -$1.39M 10-Q · filed 2011-04-21 | |||
| 2009-12-31 | $1.82M 10-K · filed 2012-02-17 | |||
| 2009-09-30 | $2.51M 10-Q · filed 2010-10-22 | |||
| 2009-06-30 | $1.04M 10-Q · filed 2010-07-23 | |||
| 2008-12-31 | -$2.42M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |